Newsletter

| May 13, 2009

IP Watch: Procter and Gamble Co. v. Teva Pharms. USA, Inc.

[To the extent that] researchers can only “vary all parameters or try each of numerous possible choices until one possibly arrive[s] at a successful result, where the prior art [gives] either no indication of which parameters [are] critical or no direction as to which of many possible choices is likely to be successful”. . . “courts should not succumb to hindsight claims of obviousness.”

For more information, please contact your Dewey & LeBoeuf relationship partner, or one of the following:

Lawrence M. Sung

+1 202 346 7850

This memorandum is intended only as a general discussion of these issues. It is not considered to be legal advice. We would be pleased to provide additional details or advice about specific situations. For additional information on this important topic, please feel free to call upon your Dewey & LeBoeuf relationship partner. No part of this publication may be reproduced, in whole or in part, in any form, without our prior written consent. For further information on Dewey & LeBoeuf, please visit www.dl.com. +1 888 532 6383